Max India Limited has informed the Exchange about change in Management

Management Changes View source PDF Explain this filing

MAXIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.1%Reaction day

₹148.60

prior close

₹151.37

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+2.1%+2.0% vs market

Holding Company peers, median of 13sector+2.5%+1.6% vs sector

On the reaction day the stock moved 2.0 pts more than Nifty Microcap 250 and 1.6 pts more than its Holding Company peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.0

10m

+0.1

15m

+0.1

30m

+0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.1+2.1+2.0+2.5+1.6

Next day

+1.0+2.1-1.0+1.5-0.4

+3.0+4.7-1.7+4.0-1.0

+2.4+5.9-3.5+3.7-1.3

+2.9+7.1-4.2+4.7-1.7

+0.8+6.5-5.7+2.0-1.1

+4.3+9.1-4.7+4.8-0.4

15d

+9.7+10.8-1.1+1.1+8.6

+16.8+12.6+4.1+1.5+15.2

+6.3+12.0-5.6-5.6+11.9

+9.2+21.4-12.3+4.5+4.6

UpDownMarket · Nifty Microcap 250Sector · Holding Company peers, median of 13Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Max India Limited's Board has approved the appointment of Ms. Mrinalini Mirchandani as an Additional Director in the capacity of Independent Director for a 5-year term from April 15, 2026 to April 14, 2031. The appointment is subject to shareholder approval. Ms. Mirchandani was previously a Senior Partner at McKinsey & Company, where she led the Private Equity Practice in India and was the first woman to be elected Senior Partner in McKinsey's 34-year history in India. She brings extensive experience in healthcare, M&A, and transformational change. She is not related to any existing directors of the company.

Likely market impact

The appointment of an experienced leader from McKinsey strengthens the board's expertise in strategy and healthcare. As an Independent Director, this enhances board independence and governance. No immediate impact on stock price expected, pending shareholder approval.